Ausdal Financial Partners, Inc. Bristol Myers Squibb CO Transaction History

Ausdal Financial Partners, Inc.

$897 Million
Q3 2024

A detailed history of Ausdal Financial Partners, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ausdal Financial Partners, Inc. holds 6,961 shares of BMY stock, worth $391,347. This represents 0.04% of its overall portfolio holdings.

Number of Shares

6,961

Previous 8,179 14.89%

Holding current value

$391,347

Previous $339,000 6.19%

% of portfolio

0.04%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$39.66 - $51.75 $48,305 - $63,031	-1,218 Reduced 14.89%	6,961 $360,000
Q2 2024 Aug 06, 2024	SELL	$40.25 - $52.99 $25,719 - $33,860	-639 Reduced 7.25%	8,179 $339,000
Q1 2024 Apr 12, 2024	BUY	$47.98 - $54.4 $14,777 - $16,755	308 Added 3.62%	8,818 $478,000
Q4 2023 Jan 11, 2024	SELL	$48.48 - $57.85 $12,750 - $15,214	-263 Reduced 3.0%	8,510 $436,000
Q3 2023 Nov 08, 2023	SELL	$57.89 - $64.73 $48,801 - $54,567	-843 Reduced 8.77%	8,773 $509,000
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $43,705 - $48,527	-686 Reduced 6.66%	9,616 $614,000
Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $106,647 - $120,962	1,623 Added 18.7%	10,302 $714,000
Q4 2022 Feb 03, 2023	BUY	$68.48 - $81.09 $19,722 - $23,353	288 Added 3.43%	8,679 $624,000
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $95 - $56,707	738 Added 9.64%	8,391 $596,000
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $16,847 - $18,555	-232 Reduced 2.94%	7,653 $589,000
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $111,401 - $133,580	1,812 Added 29.84%	7,885 $576,000
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $19,145 - $22,319	357 Added 6.25%	6,073 $379,000
Q3 2021 Nov 01, 2021	BUY	$59.17 - $69.31 $1,656 - $1,940	28 Added 0.49%	5,716 $338,000
Q2 2021 Jul 19, 2021	SELL	$61.91 - $67.42 $2,724 - $2,966	-44 Reduced 0.77%	5,688 $380,000
Q1 2021 May 05, 2021	BUY	$59.34 - $66.74 $4,865 - $5,472	82 Added 1.45%	5,732 $362,000
Q4 2020 Feb 01, 2021	SELL	$57.74 - $65.43 $5,543 - $6,281	-96 Reduced 1.67%	5,650 $350,000
Q3 2020 Nov 04, 2020	BUY	$57.43 - $63.64 $74,888 - $82,986	1,304 Added 29.36%	5,746 $346,000
Q2 2020 Aug 06, 2020	SELL	$54.82 - $64.09 $80,585 - $94,212	-1,470 Reduced 24.86%	4,442 $261,000
Q1 2020 May 04, 2020	SELL	$46.4 - $67.43 $7,006 - $10,181	-151 Reduced 2.49%	5,912 $365,000
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $298,360 - $389,183	6,063 New	6,063 $389,000
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $266,522 - $345,615	-5,466 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$55.19 - $62.25 $14,790 - $16,683	268 Added 5.16%	5,466 $339,000
Q2 2018 Aug 08, 2018	BUY	$50.53 - $62.98 $61,141 - $76,205	1,210 Added 30.34%	5,198 $288,000
Q1 2018 Apr 20, 2018	SELL	$59.92 - $68.98 $55,366 - $63,737	-924 Reduced 18.81%	3,988 $252,000
Q4 2017 Feb 08, 2018	SELL	$59.94 - $65.35 $155,784 - $169,844	-2,599 Reduced 34.6%	4,912 $301,000
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $414,832 - $478,751	7,511	7,511 $479,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ausdal Financial Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ausdal Financial Partners, Inc. with notifications on news.

Account

Ausdal Financial Partners, Inc. Bristol Myers Squibb CO Transaction History